Literature DB >> 15304310

Biphasic effect of daidzein on cell growth of human colon cancer cells.

J M Guo1, B X Xiao, D H Liu, M Grant, S Zhang, Y F Lai, Y B Guo, Q Liu.   

Abstract

Colorectal cancer is one of the most common cancers in the world, poorly responding to available chemotherapeutic agents. To investigate whether natural molecules can inhibit colon cancer progression, we investigated a principle phytoestrogen found in soybean known as daidzein, and determined its effects on the human colon cancer cell line LoVo. LoVo cells were treated with 0.1, 1, 5, 10, 50 and 100 microM daidzein for 2, 3, 4 or 5 d. The results indicated that daidzein stimulated the growth of LoVo cells at 0.1 and 1 microM whereas at higher concentrations (10, 50 and 100 microM) cell growth was inhibited in a dose-dependent manner. Treatment of daidzein at 10, 50 and 100 microM resulted in cell cycle arrest at G0/G1 phase, DNA fragmentation and increases in caspase-3 activity. There were no changes in alkaline phosphatase activity (ALP), an indicator of cell differentiation, upon treatment with daidzein when compared to controls. These results indicate that daidzein has a biphasic effect on LoVo cell growth and its tumor suppressive effect is by means of cell cycle arrest and apoptosis but not through cell differentiation. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304310     DOI: 10.1016/j.fct.2004.06.001

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  11 in total

Review 1.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses.

Authors:  Laura N Vandenberg; Theo Colborn; Tyrone B Hayes; Jerrold J Heindel; David R Jacobs; Duk-Hee Lee; Toshi Shioda; Ana M Soto; Frederick S vom Saal; Wade V Welshons; R Thomas Zoeller; John Peterson Myers
Journal:  Endocr Rev       Date:  2012-03-14       Impact factor: 19.871

2.  Soy-derived isoflavones inhibit HeLa cell growth by inducing apoptosis.

Authors:  Jun-Xia Xiao; Guo-Qing Huang; Xin Geng; Hong-Wei Qiu
Journal:  Plant Foods Hum Nutr       Date:  2011-06       Impact factor: 3.921

3.  Daidzein Induces Intrinsic Pathway of Apoptosis along with ER α/β Ratio Alteration and ROS Production.

Authors:  Vinod Kumar; Shyam S Chauhan
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

4.  Comparative effect of genistein and daidzein on the expression of MCP-1, eNOS, and cell adhesion molecules in TNF-α-stimulated HUVECs.

Authors:  Hye Yeon Cho; Chung Mu Park; Mi Jeong Kim; Radnaabazar Chinzorig; Chung Won Cho; Young Sun Song
Journal:  Nutr Res Pract       Date:  2011-10-28       Impact factor: 1.926

Review 5.  Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.

Authors:  Svjetlana Medjakovic; Monika Mueller; Alois Jungbauer
Journal:  Nutrients       Date:  2010-02-26       Impact factor: 5.717

Review 6.  Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action.

Authors:  Md Nur Alam; Muhammad Almoyad; Fazlul Huq
Journal:  Biomed Res Int       Date:  2018-01-15       Impact factor: 3.411

7.  Preparation and Pharmacokinetic Study of Daidzein Long-Circulating Liposomes.

Authors:  Qiao Wang; Wenjin Liu; Junjun Wang; Hong Liu; Yong Chen
Journal:  Nanoscale Res Lett       Date:  2019-10-15       Impact factor: 4.703

8.  Cellular and molecular alterations induced by low‑dose fisetin in human chronic myeloid leukemia cells.

Authors:  Anna Klimaszewska-Wiśniewska; Dariusz Grzanka; Paulina Czajkowska; Marta Hałas-Wiśniewska; Justyna Durślewicz; Paulina Antosik; Alina Grzanka; Maciej Gagat
Journal:  Int J Oncol       Date:  2019-10-02       Impact factor: 5.650

9.  Equol enhances tamoxifen's anti-tumor activity by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells.

Authors:  Christiana Charalambous; Chara A Pitta; Andreas I Constantinou
Journal:  BMC Cancer       Date:  2013-05-15       Impact factor: 4.430

10.  O-desmethylangolensin inhibits the proliferation of human breast cancer MCF-7 cells by inducing apoptosis and promoting cell cycle arrest.

Authors:  Eun Jeong Choi; Gun-Hee Kim
Journal:  Oncol Lett       Date:  2013-10-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.